Lyrer P
Neurologische Universitätsklinik, Kantonsspital Basel.
Schweiz Med Wochenschr. 1994 Nov 12;124(45):2005-12.
Up to the present, treatment strategies for acute cerebral ischemia have not shown scientifically proven efficacy. Based upon new knowledge on stroke pathogenesis and experimental data, new concepts of cerebral ischemia treatment are being clinically tested. The main therapeutic instrument is clot lysis by systemic or local application of thrombolytic drugs or the use of cytoprotective agents. For both treatment strategies clinical trials to show efficacy are ongoing or planned. Early reperfusion can be obtained by fibrinolysis, but its clinical usefulness has yet to be proven.
到目前为止,急性脑缺血的治疗策略尚未显示出经科学验证的疗效。基于对中风发病机制的新知识和实验数据,脑缺血治疗的新概念正在进行临床试验。主要治疗手段是通过全身或局部应用溶栓药物进行血栓溶解或使用细胞保护剂。对于这两种治疗策略,显示疗效的临床试验正在进行或已在计划之中。通过纤维蛋白溶解可以实现早期再灌注,但其临床实用性尚待证实。